| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide L Luznik, PV O'Donnell, HJ Symons, AR Chen, MS Leffell, M Zahurak, ... Biology of Blood and Marrow Transplantation 14 (6), 641-650, 2008 | 1891 | 2008 |
| Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia SO Ciurea, MJ Zhang, AA Bacigalupo, A Bashey, FR Appelbaum, ... Blood, The Journal of the American Society of Hematology 126 (8), 1033-1040, 2015 | 664 | 2015 |
| Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide PV O'donnell, L Luznik, RJ Jones, GB Vogelsang, MS Leffell, M Phelps, ... Biology of Blood and Marrow Transplantation 8 (7), 377-386, 2002 | 509 | 2002 |
| High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease L Luznik, J Bolaños-Meade, M Zahurak, AR Chen, BD Smith, R Brodsky, ... Blood, The Journal of the American Society of Hematology 115 (16), 3224-3230, 2010 | 457 | 2010 |
| HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease J Bolaños-Meade, EJ Fuchs, L Luznik, SM Lanzkron, CJ Gamper, ... Blood, The Journal of the American Society of Hematology 120 (22), 4285-4291, 2012 | 443 | 2012 |
| The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in … KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ... Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017 | 427 | 2017 |
| Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and … L Luznik, S Jalla, LW Engstrom, R Iannone, EJ Fuchs Blood, The Journal of the American Society of Hematology 98 (12), 3456-3464, 2001 | 375 | 2001 |
| Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide CG Kanakry, S Ganguly, M Zahurak, J Bolaños-Meade, C Thoburn, ... Science translational medicine 5 (211), 211ra157-211ra157, 2013 | 362 | 2013 |
| Modern approaches to HLA-haploidentical blood or marrow transplantation CG Kanakry, EJ Fuchs, L Luznik Nature reviews Clinical oncology 13 (1), 10-24, 2016 | 354 | 2016 |
| Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation L Luznik, PV O'Donnell, EJ Fuchs Seminars in oncology 39 (6), 683-693, 2012 | 343 | 2012 |
| Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed … LM Burroughs, PV O'Donnell, BM Sandmaier, BE Storer, L Luznik, ... Biology of blood and marrow transplantation 14 (11), 1279-1287, 2008 | 334 | 2008 |
| Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome YL Kasamon, L Luznik, MS Leffell, J Kowalski, HL Tsai, J Bolaños-Meade, ... Biology of Blood and Marrow Transplantation 16 (4), 482-489, 2010 | 313 | 2010 |
| Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation C Toffalori, L Zito, V Gambacorta, M Riba, G Oliveira, G Bucci, M Barcella, ... Nature medicine 25 (4), 603-611, 2019 | 307 | 2019 |
| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 302 | 2015 |
| Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using … CG Kanakry, PV O'Donnell, T Furlong, MJ De Lima, W Wei, M Medeot, ... Journal of Clinical Oncology 32 (31), 3497, 2014 | 273 | 2014 |
| Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans M Srinivasan, R Flynn, A Price, A Ranger, JL Browning, PA Taylor, J Ritz, ... Blood, The Journal of the American Society of Hematology 119 (6), 1570-1580, 2012 | 271 | 2012 |
| High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation L Luznik, EJ Fuchs Immunologic research 47, 65-77, 2010 | 256 | 2010 |
| Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults YL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, ... Journal of Clinical Oncology 33 (28), 3152, 2015 | 249 | 2015 |
| Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans R Flynn, J Du, RG Veenstra, DK Reichenbach, A Panoskaltsis-Mortari, ... Blood, The Journal of the American Society of Hematology 123 (25), 3988-3998, 2014 | 221 | 2014 |
| The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in … SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ... Bone marrow transplantation 53 (5), 521-534, 2018 | 218 | 2018 |
